16.05
Hercules Capital Inc stock is traded at $16.05, with a volume of 1.71M.
It is up +0.56% in the last 24 hours and up +5.04% over the past month.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
See More
Previous Close:
$15.96
Open:
$16.05
24h Volume:
1.71M
Relative Volume:
0.99
Market Cap:
$3.00B
Revenue:
$514.85M
Net Income/Loss:
$328.86M
P/E Ratio:
9.0392
EPS:
1.7756
Net Cash Flow:
$311.25M
1W Performance:
+1.07%
1M Performance:
+5.04%
6M Performance:
-13.76%
1Y Performance:
-13.76%
Hercules Capital Inc Stock (HTGC) Company Profile
Name
Hercules Capital Inc
Sector
Industry
Phone
650-289-3060
Address
1 NORTH B STREET, SAN MATEO, CA
Compare HTGC vs BLK, BX, BN, KKR, BAM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HTGC
Hercules Capital Inc
|
16.05 | 2.95B | 514.85M | 328.86M | 311.25M | 1.7756 |
|
BLK
Blackrock Inc
|
1,011.21 | 149.27B | 26.28B | 6.75B | 3.76B | 38.77 |
|
BX
Blackstone Inc
|
123.42 | 143.74B | 14.88B | 6.10B | 869.79M | 3.8977 |
|
BN
Brookfield Corp
|
43.96 | 95.13B | 77.61B | 4.06B | -8.36B | 0.497 |
|
KKR
Kkr Co Inc
|
95.97 | 82.41B | 22.38B | 5.74B | 8.54B | 2.9339 |
|
BAM
Brookfield Asset Management Ltd
|
47.00 | 71.62B | 5.07B | 2.48B | 2.37B | 1.5532 |
Hercules Capital Inc Stock (HTGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-04-25 | Upgrade | Compass Point | Neutral → Buy |
| Dec-12-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Jan-16-24 | Downgrade | Compass Point | Buy → Neutral |
| Nov-21-23 | Initiated | UBS | Neutral |
| Aug-30-23 | Upgrade | Compass Point | Neutral → Buy |
| Aug-04-23 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Apr-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-13-23 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Jul-29-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-22-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Apr-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-08-22 | Downgrade | Compass Point | Buy → Neutral |
| Apr-28-21 | Initiated | Oppenheimer | Outperform |
| Mar-25-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-02-20 | Resumed | JMP Securities | Mkt Outperform |
| Jul-31-20 | Upgrade | Compass Point | Neutral → Buy |
| Jul-20-20 | Resumed | Piper Sandler | Overweight |
| Jun-19-20 | Upgrade | Janney | Neutral → Buy |
| Mar-31-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-04-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| May-06-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Mar-13-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Mar-13-19 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Feb-07-18 | Upgrade | Wedbush | Neutral → Outperform |
| Feb-06-18 | Upgrade | Sandler O'Neill | Hold → Buy |
| Nov-20-17 | Initiated | Ladenburg Thalmann | Buy |
| Nov-03-17 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Oct-25-17 | Initiated | Wedbush | Neutral |
| Oct-02-17 | Resumed | FBR & Co. | Buy |
| Sep-08-17 | Upgrade | Compass Point | Neutral → Buy |
| Aug-07-17 | Resumed | JMP Securities | Mkt Outperform |
| Aug-04-17 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Feb-24-17 | Reiterated | FBR & Co. | Outperform |
View All
Hercules Capital Inc Stock (HTGC) Latest News
Hercules Capital, Inc. (HTGC) Investigation: Bronstein, Gewirtz - The National Law Review
HTGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
HTGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
4DMT SECURES STRATEGIC CREDIT FACILITY FOR UP TO $200 MILLION FROM HERCULES CAPITAL - Moomoo
Hercules Capital, Inc. Actuals & Estimates (NYSE:HTGC) - TradingView
4D Molecular Therapeutics secures $200M credit facility - Investing.com UK
4D Molecular Therapeutics Secures Strategic Credit Facility for Up to $200 Million from Hercules Capital - marketscreener.com
4D Molecular Therapeutics Secures Up to $200 Million Term Loan Facility From Hercules Capital - TradingView
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital - The Manila Times
Press Release: 4DMT Secures Strategic Credit Facility for up to $200 Million From Hercules Capital - Moomoo
HTGCHercules Capital Inc Latest SEC Filings - Finviz
What's Behind the Sudden Surge in Bearish Bets on Hercules Capital - Kavout | AI
Price to earnings forward of Hercules Capital, Inc. – NYSE:HTGC - TradingView
Price to sales forward of Hercules Capital, Inc. – NYSE:HTGC - TradingView
Price to earnings forward of Hercules Capital, Inc. – HAM:19H - TradingView
Price to book forward of Hercules Capital, Inc. – HAM:19H - TradingView
Enterprise value to revenue forward of Hercules Capital, Inc. – HAM:19H - TradingView
Price to sales forward of Hercules Capital, Inc. – HAM:19H - TradingView
(HTGC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Enterprise value to revenue forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Price to book forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
19H Forecast — Price Target — Prediction for 2027 - TradingView
Hercules Capital, Inc. Actuals & Estimates (LSE:0J4M) - TradingView
Price to earnings forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Enterprise value to EBIT forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Price to sales forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Dyne Therapeutics (DYN) Expands Term Loan Facility with Hercules Capital by $400M to Advance Clinical Pipeline - Insider Monkey
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet - Yahoo Finance
Hercules Capital Inc (HTGC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half (NYSE:HTGC) - Seeking Alpha
Form 4 Hercules Capital Inc For: 23 June By Investing.com - Investing.com South Africa
Hercules Capital (HCXY) director gets 3,873-share restricted stock award - Stock Titan
Director Robert Badavas gets 3,873-share grant at Hercules Capital (HCXY) - Stock Titan
Hercules Capital (NYSE: HTGC) director receives 3,873-share restricted stock award - Stock Titan
Hercules Capital (NYSE: HTGC) director receives 3,873-share restricted grant - Stock Titan
2 Reasons to Avoid HTGC and 1 Stock to Buy Instead - Yahoo Finance
Hercules Capital Faces Its Own 12 Labors (NYSE:HTGC) - Seeking Alpha
Technical Reactions to HCXY Trends in Macro Strategies - Stock Traders Daily
HTGC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Hercules Capital Stockholders Approve Governance and Compensation Measures - The Globe and Mail
Hercules Capital, Inc. 2026 Annual Meeting Results: Director Election, Executive Compensation, and Equity Plan Amendments Approved - Minichart
Hercules Capital Inc (HTGC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Hercules Capital (HCXY) investors back director, pay plans and auditor at 2026 meeting - Stock Titan
Hercules Capital (HTGC) AGM 2026 Summary - Quartr
Hercules Capital Inc (HTGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hercules Capital Inc (HTGC) Institutional Confidence - TradingKey
Hercules Capital Inc (HTGC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Hercules Capital Inc (HTGC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. - Investing News Network
Dyne Therapeutics Expands Hercules Capital Debt Facility to Up to $400 Million - citybiz
Hercules Capital Inc Stock (HTGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hercules Capital Inc Stock (HTGC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Loo Wade | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
14,050 |
| Fallon Thomas J | Director |
Mar 26 '26 |
Buy |
14.30 |
7,300 |
104,390 |
157,669 |
| Aguirre DeAnne | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
10,749 |
| Randhawa Paramjeet K | Director |
Mar 26 '26 |
Buy |
14.35 |
2,926 |
41,988 |
22,486 |
| CROWELL GAYLE A | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
97,589 |
| Theodosopoulos Nikos | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
29,362 |
| Randhawa Paramjeet K | Director |
Mar 04 '26 |
Buy |
14.78 |
3,050 |
45,079 |
19,560 |
| Theodosopoulos Nikos | Director |
Feb 27 '26 |
Buy |
14.21 |
2,600 |
36,946 |
21,523 |
| BADAVAS ROBERT P | Director |
Feb 27 '26 |
Buy |
14.27 |
5,000 |
71,350 |
122,073 |
| Botelho Kiersten Zaza | Chief Legal Officer & CCO |
Feb 27 '26 |
Buy |
14.21 |
1,300 |
18,473 |
93,336 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):